Combination Therapy with Finerenone and Empagliflozin by Baseline Risk of Liver Fibrosis in the CONFIDENCE Trial (AHA 2026) - Sep 5, 2026 - Abstract #MDP1991; Pres time: Nov 9, 2026; 09:43 AM - 09:48 AM; Location: Moderated Digital Poster 19‚ Population Science Zone; In-Person; No abstract available
Combination therapy • Fibrosis • Hepatology • Immunology • Liver Cirrhosis
|
|
Rajiv Agarwal; Brian Claggett; Jennifer Green; Ragnhild Helseth; Lucas Hofmeister; Li Li; Janet McGill; Amy Mottl; Masaomi Nangaku; Julio Rosenstock; Peter Rossing; Charlie Scott; Muthiah Vaduganathan
|